Cargando…

Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study

AIM: To identify risk factors associated with hepatocellular carcinoma (HCC), describe tumor characteristics and treatments pursed for a cohort of individuals with nonalcoholic steatohepatitis (NASH) cirrhosis. METHODS: We conducted a retrospective case-control study of a well-characterized cohort o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corey, Kathleen E, Gawrieh, Samer, deLemos, Andrew S, Zheng, Hui, Scanga, Andrew E, Haglund, Jennifer W, Sanchez, Jorge, Danford, Christopher J, Comerford, Megan, Bossi, Krista, Munir, Samina, Chalasani, Naga, Wattacheril, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Case Control Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340993/ https://www.ncbi.nlm.nih.gov/pubmed/28321274 http://dx.doi.org/10.4254/wjh.v9.i7.385

Ejemplares similares

Distinctive Features and Outcomes of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Disease: A US Multicenter Study
por: deLemos, Andrew, et al.
Publicado: (2020)

Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort
por: Pomenti, Sydney, et al.
Publicado: (2020)

Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents
por: Mathur, Karan, et al.
Publicado: (2021)

Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans
por: Liu, Wanqing, et al.
Publicado: (2016)

Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis
por: Allende, Daniela S, et al.
Publicado: (2021)

Integrative omics analysis identifies macrophage migration inhibitory factor signaling pathways underlying human hepatic fibrogenesis and fibrosis
por: Liu, Zhipeng, et al.
Publicado: (2019)

Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis
por: Noureddin, Mazen, et al.
Publicado: (2023)

Dynamic Alterations to Hepatic MicroRNA-29a in Response to Long-Term High-Fat Diet and EtOH Feeding
por: Liang, Tiebing, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
por: Masuoka, Howard C, et al.
Publicado: (2013)

Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease
por: Yates, Katherine P., et al.
Publicado: (2017)

Systemic Causes of Cholestasis
por: deLemos, Andrew S., et al.
Publicado: (2013)

Automated assessment of steatosis in murine fatty liver
por: Sethunath, Deepak, et al.
Publicado: (2018)

Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden
por: Dakhoul, Lara, et al.
Publicado: (2018)

Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
por: Klebanoff, Matthew J., et al.
Publicado: (2019)

Risk of progression of Barrett's esophagus in patients with cirrhosis
por: Apfel, Tehilla, et al.
Publicado: (2017)

Extrahepatic Autoimmune Diseases are Prevalent in Autoimmune Hepatitis Patients and Their First-Degree Relatives: Survey Study
por: Fogel, Rachel, et al.
Publicado: (2018)

Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis
por: Orman, Eric S., et al.
Publicado: (2019)

GDF8 Contributes to Liver Fibrogenesis and Concomitant Skeletal Muscle Wasting
por: Culver, Alexander, et al.
Publicado: (2023)

Polymorphisms of folate metabolism genes in patients with cirrhosis and hepatocellular carcinoma
por: Peres, Nathália Perpétua, et al.
Publicado: (2016)

Gastric food retention at endoscopy is associated with severity of liver cirrhosis
por: Snell, David B, et al.
Publicado: (2019)

Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Changing the face of hepatitis C management – the design and development of sofosbuvir
por: Noell, Bennett C, et al.
Publicado: (2015)

Bleeding After Elective Interventional Endoscopic Procedures in a Large Cohort of Patients With Cirrhosis
por: Kundumadam, Shanker, et al.
Publicado: (2020)

Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial
por: Gawrieh, Samer, et al.
Publicado: (2021)

Leveraging Social Networking Sites for an Autoimmune Hepatitis Genetic Repository: Pilot Study to Evaluate Feasibility
por: Comerford, Megan, et al.
Publicado: (2018)

Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
por: Seen, Tasur Kumar, et al.
Publicado: (2021)

PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
por: Lisboa, Quelson Coelho, et al.
Publicado: (2020)

Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis
por: Phatharacharukul, Parkpoom, et al.
Publicado: (2020)

Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis
por: Chalasani, Naga, et al.
Publicado: (2023)

Progressive Cholestasis and Biliary Cirrhosis After Initiating Oral Semaglutide: Report From the Drug-Induced Liver Injury Network
por: Ma, Jiayi, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus
por: Gawrieh, Samer, et al.
Publicado: (2023)

Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial
por: Maslennikov, Roman, et al.
Publicado: (2022)

Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis
por: Wattacheril, Julia, et al.
Publicado: (2013)

Diastolic Dysfunction and Severity of Cirrhosis in Nonalcoholic Cirrhotic Patients
por: Salari, A., et al.
Publicado: (2013)

Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis
por: Gelman, Sigita, et al.
Publicado: (2019)

Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis
por: Sak, Jarosław Jerzy, et al.
Publicado: (2021)

Phosphatidylethanolamines Are Associated with Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Adults and Induce Liver Cell Metabolic Perturbations and Hepatic Stellate Cell Activation
por: Shama, Samaa, et al.
Publicado: (2023)

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
por: Sanyal, Arun J., et al.
Publicado: (2022)

Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation
por: Ngwa, Taiwo, et al.
Publicado: (2020)

Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database
por: Desai, Archita P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gl2n8dgfaecvq7cl2hkm766cee